TFE3-expressing perivascular epithelioid cell tumor of the breast

Research output: Contribution to journalArticlepeer-review

Abstract

Perivascular epithelioid cell tumor (PEComa) is a very rare mesenchymal tumor with a distinctive morphology and immunophenotype. PEComas usually harbor TSC2 alterations, although TFE3 translocations, which occur in MiT family translocation renal cell carcinoma and alveolar soft part sarcoma, are also possible. We recently experienced a case of PEComa with TFE3 expression arising in the breast. An 18-year-old female patient presented with a right breast mass. Histologically, the tumor consisted of epithelioid cells with alveolar structure and showed a diffuse strong expression of HMB45 and TFE3. TSC2 was preserved. Melan A and smooth muscle actin were negative. To our knowledge, this is the first Korean case of PEComa of the breast that intriguingly presented with TFE3 expression.

Original languageEnglish
Pages (from-to)62-65
Number of pages4
JournalJournal of Pathology and Translational Medicine
Volume53
Issue number1
DOIs
StatePublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Breast
  • Perivascular epithelioid cell neoplasms
  • TFE3

Fingerprint

Dive into the research topics of 'TFE3-expressing perivascular epithelioid cell tumor of the breast'. Together they form a unique fingerprint.

Cite this